OpenSpecimen is a highly configurable Biobanking LIMS platform used in 90+ biobanks across 20+ countries. Established in 2009 and headquartered in India, it caters to the Information Technology industry. The platform is widely utilized by renowned academic research centers such as Oxford Univ, Johns Hopkins, Emory, UPitt, UPenn, Univ of Leicester, Univ of Western Australia, Univ of New South Wales, Univ of Melbourne, and Singapore General Health. Noteworthy is the absence of public details on its last investment and investors. OpenSpecimen's success in establishing a global footprint within the biobanking industry positions it as an intriguing prospect for investment and potential expansion. For further information, visit www.openspecimen.org.
There is no investment information
No recent news or press coverage available for OpenSpecimen (Biobanking LIMS).